Insulin resistance and hyperinsulinemia accompanied by NAFLD may be involved in liver tumorigenesis by activating intracellular signaling pathways, such as the PI3K/Akt/mTOR pathway (39). The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.